Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase 2

Completed

• Conditions: Ocular Hypertension

• Registration Number: NCT00332345
• Lead Sponsor: Allergan

Brief Summary

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

Detailed Description

Not available

Study Timeline

• Study Start: 1999-07
• Primary Completion: 1999-08
• Study Completion: 1999-08
• Study First Submitted: 2006-05-30
• Study First Submitted QC: 2006-05-30
• Study First Posted: 2006-06-01
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-27
• Last Update Posted: 2011-05-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 73

Inclusion Criteria

• Clinical diagnosis of glaucoma or ocular hypertension in both eyes
• Patient requires IOP-lowering in both eyes

Exclusion Criteria

• Uncontrolled medical conditions
• Contraindication to beta-andrenoceptor antagonist or brimonidine therapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
IOP